Natalie E Dean

Two-stage adaptive enrichment design for testing an active factor

Samuel S Wu, A Adam Ding, Natalie E Dean, 2020, Journal of biopharmaceutical statistics.

DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.

M Elizabeth Halloran, Ira M Longini, Natalie E Dean, 2018, The annals of applied statistics.

Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone

Abdul Kamara, M Elizabeth Halloran, Wu-Chun Cao, 2016, Proceedings of the National Academy of Sciences.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

John-Arne Røttingen, Sema Mandal, Matthias Egger, 2015, The Lancet.

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

John-Arne Røttingen, Sema Mandal, Matthias Egger, 2017, The Lancet.

Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.

Philip R Krause, Thomas Jaki, M Elizabeth Halloran, 2020, The New England journal of medicine.

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report

Mosoka P. Fallah, Pierre-Stéphane Gsell, Ana Maria Henao-Restrepo, 2017, The Lancet. Infectious diseases.